RxAmerica, L.L.C. Sustainability Profile
RxAmerica, L.L.C., headquartered in the United States, is a prominent player in the pharmacy benefit management (PBM) industry. Founded in the early 2000s, the company has established itself as a trusted partner for health plans, employers, and government entities, providing innovative solutions to manage prescription drug costs effectively. With a focus on delivering comprehensive pharmacy services, RxAmerica offers a range of products, including formulary management, medication therapy management, and cost containment strategies. Their unique approach combines advanced technology with personalised service, ensuring clients receive tailored solutions that meet their specific needs. Recognised for its commitment to quality and efficiency, RxAmerica has achieved significant milestones in optimising pharmacy benefits, positioning itself as a leader in the market. The company continues to enhance its offerings, striving to improve health outcomes while reducing overall healthcare expenses.
DitchCarbon Score
How does RxAmerica, L.L.C.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Insurance Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RxAmerica, L.L.C.'s score of 87 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RxAmerica, L.L.C., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of CVS Health Corporation, any climate commitments or emissions data would be inherited from this parent organisation. While no absolute emissions figures are provided, RxAmerica is aligned with CVS Health's sustainability initiatives, which include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to reduce greenhouse gas emissions across various scopes, although specific reduction targets for RxAmerica have not been disclosed. As part of CVS Health Corporation's broader climate strategy, RxAmerica is expected to contribute to the overarching goals set by its parent company, which may include significant reductions in Scope 1, 2, and 3 emissions. However, without specific data or targets outlined for RxAmerica, the details of their individual commitments remain vague. In summary, while RxAmerica does not currently report specific emissions data or reduction targets, it is positioned within the sustainability framework of CVS Health Corporation, which is actively engaged in climate action and emissions reduction efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 157,199,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,036,690,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 24,608,123,000 | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is RxAmerica, L.L.C.'s Industry?
How Carbon Intensive is RxAmerica, L.L.C.'s Location?
RxAmerica, L.L.C.'s Scope 3 Categories Breakdown
RxAmerica, L.L.C.'s Scope 3 emissions, which increased by 9% last year and decreased by approximately 54% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 87% of Scope 3 emissions.
Top Scope 3 Categories
RxAmerica, L.L.C.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RxAmerica, L.L.C. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
